Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Tech Cabo Verde.
Press releases published on June 23, 2025
MBX Biosciences Appoints Andreas Moraitis, M.D., as Senior Vice President of Clinical Development
GlobeNewswire
·
June 23, 2025
CARMEL, Ind., June 23, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic …
Chiesi Global Rare Diseases Awards Research Grants to Advance Innovation in Lysosomal Diseases
GlobeNewswire
·
June 23, 2025
PARMA, Italy, June 23, 2025 (GLOBE NEWSWIRE) -- Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people living with rare diseases, today announced the recipients of its "Find For …
Optime Care Partners with Tilde Sciences as Exclusive Specialty Pharmacy Provider for Vecamyl
GlobeNewswire
·
June 23, 2025
ST. LOUIS, June 23, 2025 (GLOBE NEWSWIRE) -- Optime Care, AscellaHealth’s Specialty Pharmacy, is pleased to announce an expanded partnership with Tilde Sciences LLC (“Tilde”), effective June 23, 2025. Under this arrangement, Optime Care will serve as the …
Data Demonstrating Sotagliflozin Reduces the Risk of Clinically Important Hypoglycemic Events in Adults with Type 1 Diabetes When Added to Insulin Presented at the 85th Scientific Sessions of the American Diabetes Association (ADA)
GlobeNewswire
·
June 23, 2025
Oral presentation highlighted the post-hoc analysis during the “Interventions to Prevent Hypoglycemia: Bench to Bedside” session Treatment with sotagliflozin resulted in no increased risk and a reduction in hypoglycemia events, particularly in patients …
ORYZON Announces Submission of Phase III Protocol to FDA to Initiate PORTICO-2 Trial of Vafidemstat in Borderline Personality Disorder (BPD) Patients
GlobeNewswire
·
June 23, 2025
PORTICO-2 designed to validate vafidemstat’s efficacy in reducing aggression in BPD patients Primary endpoint: STAXI-2 Trait Anger (patient-reported) Key secondary endpoint: Overt Aggression Scale-Modified (OAS-M) (clinician-rated) Additional secondary …
RAPT Therapeutics Names Two Industry Veterans to its Board of Directors
GlobeNewswire
·
June 23, 2025
SOUTH SAN FRANCISCO, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living …
ALL4 Mining Expands Affiliate Program to Fuel Platform Growth and Community Engagement
GlobeNewswire
·
June 23, 2025
Los Angeles, California , June 23, 2025 (GLOBE NEWSWIRE) -- In response to rapid platform growth and increased global demand, ALL4 Mining has officially expanded its affiliate program, marking a major milestone on its development roadmap. The upgraded …
SunnyMining Upgrades Its Intelligent Computing System to Comprehensively Improve Bitcoin (BTC) and Dogecoin (DOGE) Mining Efficiency and Profit Potential
GlobeNewswire
·
June 23, 2025
Chicago, IL, June 23, 2025 (GLOBE NEWSWIRE) -- SunnyMining announced today that it has completed a comprehensive upgrade of its intelligent computing system, which will comprehensively improve the mining efficiency and profit potential of mainstream …
Earn Mining Expands Eco-Mining Infrastructure to Lead the Next Generation of Sustainable Cloud Mining
GlobeNewswire
·
June 23, 2025
San Francisco, CA , June 23, 2025 (GLOBE NEWSWIRE) -- Earn Mining, a global leader in cloud-based cryptocurrency mining, has officially announced major upgrades to its eco-mining infrastructure. Now powered entirely by solar and wind energy, the company’s …
Grace Therapeutics Announces 2025 Fiscal Year-End Results, Provides Business Update
GlobeNewswire
·
June 23, 2025
Held Type C meeting with FDA on Planned New Drug Application (NDA) Submission, Including Clinical, Non-clinical, and Chemistry, Manufacturing, and Control (CMC) Requirements NDA On Track for Submission to FDA in First Half of Calendar 2025 NDA to be …
Immutep Announces Positive Update from Phase I Study of IMP761, a First-in-Class LAG-3 Agonist Antibody for Autoimmune Diseases
GlobeNewswire
·
June 23, 2025
Initial pharmacological data from placebo-controlled, double-blind Phase I study shows significant T cell suppression and a favourable safety profile at dosing level of 0.9 mg/kg The substantial reduction in T cell activity highlights the potential …
Opus Genetics Awarded Non-Dilutive Funding from the RD Fund to Support Preclinical Development of OPGx-MERTK Program
GlobeNewswire
·
June 23, 2025
RESEARCH TRIANGLE PARK, N.C., June 23, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biopharmaceutical company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and small molecule …
EMEET Launches PIXY: The World’s First Dual-Camera AI PTZ 4K Webcam
GlobeNewswire
·
June 23, 2025
SHENZHEN, China, June 23, 2025 (GLOBE NEWSWIRE) -- EMEET, the world’s leading webcam brand, is proud to reveal PIXY, its most versatile webcam yet. PIXY is the world’s first dual-camera AI-powered PTZ (pan, tilt, zoom) 4K webcam, with features like super- …
Data from the Phase 2 Clinical Trial of CX11/VCT220 in China Presented at ADA 2025
GlobeNewswire
·
June 23, 2025
Patients treated with CX11 (also designated as VCT220) achieved a 9.7% and 9.4% decrease in body weight from baseline after 16 weeks (p≤0.001) in the 160 mg fast and slow titration cohorts, respectively. Results suggest a favorable tolerability profile, …
Jupiter Neurosciences Names Golf Legend Annika Sörenstam as First Nugevia™ Brand Ambassador
GlobeNewswire
·
June 23, 2025
Partnership supports near-term launch of new longevity supplement line powered by clinical science and performance-driven innovation Jupiter, Florida, June 23, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) today announced that Annika …
Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary
GlobeNewswire
·
June 23, 2025
FLORHAM PARK, N.J., June 23, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced the appointment …
Clearmind Medicine Adds Leading Israeli Clinical Site to Its Ongoing Clinical Trial for Alcohol Use Disorder
GlobeNewswire
·
June 23, 2025
Vancouver, Canada, June 23, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
Dr Ashleys Limited and Impact BioMedical Inc. Announce Strategic Merger
GlobeNewswire
·
June 23, 2025
A Strategic Move to Accelerate Market Reach for Innovative Pharmaceutical Patents on June 23, 2025 NEW YORK, June 23, 2025 (GLOBE NEWSWIRE) -- Dr Ashleys Limited, a Hong Kong based global pharmaceutical company (“Dr Ashleys”), and Impact BioMedical Inc. (“ …
NETCLASS TECHNOLOGY INC and Nanyang Institute of Social Sciences Join Forces to Explore New Paths in Smart Education
GlobeNewswire
·
June 23, 2025
SHANGHAI and HONG KONG, June 23, 2025 (GLOBE NEWSWIRE) -- NETCLASS Technology INC (Nasdaq: NTCL; the “Company” or “NetClass”), a leading B2B smart education IT solutions provider with offices in Shanghai, Hong Kong, Singapore and Tokyo, is pleased to …
New Wave Announces Non-Brokered Private Placement of Units
GlobeNewswire
·
June 23, 2025
Vancouver, BC, June 23, 2025 (GLOBE NEWSWIRE) -- New Wave Holdings Corp., to be renamed Humanoid Global Holdings Corp., (“New Wave” or the “Company”) (CSE:NWAI, FWB:0XM0, OTCPK:TRMNF) is pleased to announce that it will proceed with a non-brokered private …